Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Krystal Biotech, Inc. (KRYS) had Pre-Tax Profit Margin of 49.05% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$97.80M |
|
$79.36M |
|
$4.26M |
|
$93.54M |
|
$56.43M |
|
$41.37M |
|
$6.59M |
|
$47.97M |
|
$47.97M |
|
$79.36M |
|
$79.36M |
|
$79.36M |
|
$79.36M |
|
$41.37M |
|
$42.99M |
|
28.95M |
|
29.83M |
|
$2.74 |
|
$2.66 |
|
| Balance Sheet Financials | |
$925.65M |
|
$148.87M |
|
$314.44M |
|
$1.24B |
|
$91.27M |
|
-- |
|
$10.95M |
|
$102.22M |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
28.98M |
|
| Cash Flow Statement Financials | |
$123.36M |
|
$-69.58M |
|
$-6.96M |
|
$344.87M |
|
$392.60M |
|
$47.74M |
|
$40.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.64% |
|
42.30% |
|
42.30% |
|
-- |
|
|
Pre-Tax Profit Margin |
49.05% |
81.15% |
|
$113.98M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.11 |
|
0.75 |
|
119.29 |
|
6.97% |
|
6.97% |
|
6.40% |
|
6.97% |
|
$39.26 |
|
$3.82 |
|
$4.13 |
|